adenosine

Key facts

INN

adenosine

Brand

ADENOSINE

Route

INJECTION

Formulation

INJECTABLE

Originator

Regen BioPharma Inc

Related patents

patent

US 12378248

A1 adenosine receptor agonists and methods of use thereof

Expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12325708

Adenosine 2 receptor antagonists

Expires Mon Jun 05 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12310965

Treatment of cancer utilizing an identified adenosine fingerprint

Expires Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12213990

A3 adenosine receptor ligand for use for achieving a fat loss effect

Expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12174192

Methods for detecting and treating cancers having adenosine pathway activation

Expires Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12168023

Inhibitors of adenosine 5′-nucleotidase

Expires Mon Dec 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12116635

Methods for detecting and treating cancers having adenosine pathway activation

Expires Mon Oct 10 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 11795443

Uses of adenosine base editors

Expires Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

Frequently asked questions

What is adenosine?

adenosine (ADENOSINE), is a pharmaceutical active ingredient, associated with Regen BioPharma Inc, with approved status in the US.

What is the brand name for adenosine?

ADENOSINE is a marketed brand name for adenosine. Check FDA Drugs@FDA for the current US label holder.